David Johnson Einstein
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
-
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
Papers in
-
- Prostate Cancer Treatment and Research 13
- Renal cell carcinoma treatment 4
- Prostate Cancer Diagnosis and Treatment 4
- Oncology 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Steven P. Balk (10 shared papers)Guru Sonpavde (2 shared papers)Seiji Arai (2 shared papers)Brian T. Halbert (2 shared papers)David F. McDermott (6 shared papers)Olga S. Voznesensky (5 shared papers)Huihui Ye (3 shared papers)Mary Kathleen Buss (2 shared papers)
- Journals
- Clinical Cancer Research (3 papers)JCO Precision Oncology (3 papers)Nature Communications (3 papers)Current Opinion in Oncology (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
David Johnson Einstein
47 papers receiving 787 citations
Peers
Comparison fields: 5 of 42
- Pulmonary and Respiratory Medicine 296
- Oncology 109
- Cancer Research 46
- Immunology 23
- Public Health, Environmental and Occupational Health 38
Countries citing papers authored by David Johnson Einstein
This map shows the geographic impact of David Johnson Einstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Johnson Einstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Johnson Einstein more than expected).
Fields of papers citing papers by David Johnson Einstein
This network shows the impact of papers produced by David Johnson Einstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Johnson Einstein. The network helps show where David Johnson Einstein may publish in the future.
Co-authors
The 25 scholars most cited alongside David Johnson Einstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 198 | |
| 2 | 2019 | 66 | |
| 3 | 2020 | 61 | |
| 4 | 2021 | 56 | |
| 5 | 2019 | 40 | |
| 6 | 2021 | 36 | |
| 7 | 2019 | 28 | |
| 8 | 2023 | 27 | |
| 9 | 2017 | 26 | |
| 10 | 2020 | 25 | |
| 11 | 2018 | 24 | |
| 12 | 2022 | 22 | |
| 13 | 2024 | 20 | |
| 14 | 2022 | 18 | |
| 15 | Combined blockade of vascular endothelial growth factor and programmed death 1 pathways in advanced kidney cancer. | 2017 | 13 |
| 16 | 2019 | 13 | |
| 17 | 2021 | 13 | |
| 18 | 2024 | 11 | |
| 19 | 2016 | 10 | |
| 20 | 2020 | 10 |
About David Johnson Einstein
David Johnson Einstein is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Public Health, Environmental and Occupational Health, Family Practice and Surgery, having authored 49 papers that have together received 799 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Palliative Care and End-of-Life Issues (4 papers), Renal cell carcinoma treatment (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), Nutrition and Health in Aging (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (296 citations), Oncology (109 citations), Cancer Research (46 citations), Immunology (23 citations) and Public Health, Environmental and Occupational Health (38 citations). David Johnson Einstein has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Steven P. Balk, Guru Sonpavde, Seiji Arai, Brian T. Halbert, David F. McDermott, Olga S. Voznesensky, Huihui Ye, Mary Kathleen Buss, Fatima H. Karzai and Peter Chang. Their work appears in journals such as Clinical Cancer Research, JCO Precision Oncology, Nature Communications, Current Opinion in Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.